Results 41 to 50 of about 1,406,764 (353)

Cardiogenic Shock After Acute Myocardial Infarction A Review

open access: yesJournal of the American Medical Association (JAMA), 2021
IMPORTANCE Cardiogenic shock affects between 40 000 and 50 000 people in the US per year and is the leading cause of in-hospital mortality following acute myocardial infarction. OBSERVATIONS Thirty-day mortality for patients with cardiogenic shock due to
Marc D. Samsky   +5 more
semanticscholar   +1 more source

Class of antiretroviral drugs and the risk of myocardial infarction [PDF]

open access: yes, 2007
BACKGROUND:We have previously demonstrated an association between combination antiretroviral therapy and the risk of myocardial infarction. It is not clear whether this association differs according to the class of antiretroviral drugs.
El-Sadr, W   +44 more
core   +1 more source

A crisis-oriented approach to the rehabilitation of myocardial infarction patients [PDF]

open access: yes, 1981
Bibliography: leaf 111-124.Myocardial infarction is introduced as a medical syndrome in which psychosocial factors are thought to have significant bearing on the etiology and outcome of the disease.
Sonnenberg, David Max
core   +1 more source

Bivalirudin during primary PCI in acute myocardial infarction. [PDF]

open access: yes, 2008
BACKGROUND: Treatment with the direct thrombin inhibitor bivalirudin, as compared with heparin plus glycoprotein IIb/IIIa inhibitors, results in similar suppression of ischemia while reducing hemorrhagic complications in patients with stable angina and ...
Kirtane, Ajay J   +15 more
core   +1 more source

Long-term mortality after first Acute Myocardial Infarction in the light of changing therapeutic guidelines and diagnostic criteria between 1995 and 2003 [PDF]

open access: yes, 2010
Background: The introduction of new invasive therapies for acute myocardial infarction and new medication schemes for secondary prevention is thought to increase life expectancy in 28-day survivors of a first myocardial infarction.
Kandler, Ulla
core   +1 more source

Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. [PDF]

open access: yes, 2009
BACKGROUND: There is no consensus regarding the safety and efficacy of drug-eluting stents, as compared with bare-metal stents, in patients with ST-segment elevation myocardial infarction who are undergoing primary percutaneous coronary intervention (PCI)
Brodie, Bruce R.   +23 more
core   +1 more source

Psoriasis is an independent predictor of increased risk of allergic reaction during percutaneous coronary interventions. Big data analysis from the Polish National PCI Registry (ORPKI)

open access: yesCardiology Journal, 2020
BACKGROUND: The presence of psoriasis is currently considered by the European Society of Cardiology cardiovascular prevention guidelines of 2016 as one possible cardiovascular risk factor.
Zbigniew Siudak   +6 more
doaj   +1 more source

Cerebral Infarction in Acute Anemia

open access: yes, 2011
There are few previous studies on the relationship between cerebral infarction and acute anemia. This study presents patients with cerebral infarction in acute anemia due to marked blood loss and aims to clarify the stroke nature and possible mechanism ...
蔡忠芬;葉炳强;葉馨喬;鄭建興   +1 more
core   +1 more source

Not Just Fat: Imaging in Abdominal Fat Pathology

open access: yesJournal of Gastrointestinal and Abdominal Radiology, 2021
Fat in abdomen has diverse distribution and function. Insult to fat due to several causes can result in infarction or necrosis and present as acute abdomen clinically.
Aruna R. Patil   +3 more
doaj   +1 more source

Determination of Nitric Oxide and Its Metabolites in Biological Tissues Using Ozone-Based Chemiluminescence Detection: A State-of-the-Art Review

open access: yesAntioxidants
Ozone-based chemiluminescence detection (CLD) has been widely applied for determining nitric oxide (•NO) and its derived species in many different fields, such as environmental monitoring and biomedical research.
Junjie Li   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy